martes, 29 de marzo de 2022

Phase 4 study confirms DTwP-HBV/Hib vaccine safety in pediatric patients

Phase 4 study confirms DTwP-HBV/Hib vaccine safety in pediatric patients

No hay comentarios:

Publicar un comentario